INDICAL is a leading solution provider for diagnostic workflows, the protocols for their use, and the support that empowers our customers every day. Our customers play a central role in protecting the health of animals and humans worldwide – that is why nothing matters more to us than improving your ability to do so.

Our mission:

Improving diagnostics
for better animal and
health together

For decades we have been passionately serving and working closely with private and state diagnostic laboratories to drive innovation that raises standards – ensuring you can produce reliable results today, and have certainty for the future.

Today, INDICAL is an independent company with renewed focus and ambition to pursue our mission with even greater impact.


Our story began in 1996, when Labor Diagnostik Leipzig (LDL) was founded as a service laboratory for Vets. Since then, we have established ourselves as an innovative and reliable company, focused on working with and supporting our customers to improve diagnostics.


- LDL is founded in Leipzig, Germany.
- 1999 Launch of the first commercially available ELISA in Germany for detection of Salmonella antibodies


- Introduction of the BACTOTYPE® PCR line.


- Introduction of the first VIROTYPE® real-time RT-PCR test kit (VIROTYPE® BVDV)


- Introduction of CATTLETYPE® MAP Ab for detection of antibodies to Mycobacterium avium subsp. paratuberculosis.


- Launch of PIGTYPE® Trichinella, CATTLETYPE® BHV1 gB Ab and VIROTYPE® BTV test kits.


- Introduction of VIROTYPE® BTV Plus, the first real-time Multiplex RT-PCR test kit for veterinary medicine registered in Germany.


- LDL is acquired by QIAGEN, a world leader in DNA extraction, sequencing and bioinformatics for human and life science applications. As part of QIAGEN, we proved our successes and strengthened our capabilities within molecular diagnostics within the veterinary space.


- INDICAL is an independent company with renewed focus and ambition to achieve our mission. Our strategic partnership with QIAGEN continues into the future, aimed at driving innovation together, with customers, to improve diagnostics.

Global Presence

In addition to growing our teams globally, we develop strong partnerships with local distributors in the countries we serve, to get as close to our customers as possible – so we can improve diagnostics together, no matter where you are located.

  • Local presence in 169 countries
  • Direct presence in 22 countries
  • 75+ Commercial Partners actively distributing our products in 147 countries


Decades of industry experience: Our expert team consists of vets, molecular biologists, biochemists, immunologists and technical assistants as well as sales specialists and marketing experts. See below to quickly find the people you need to contact.

Dr. Fredrik Ullman

Tel.: +49 341 12454 0
Fax: +49 341 12454 60

Dr. Claudia Engemann

Director R&D
Tel: +49 341 12454 10
Fax: +49 341 12454 60

Dr. med. vet. Carsten Schroeder

Director Global Business Development
Tel.: +49 341 12454 25
Fax: +49 341 12454 60

Dr. Stephen Hennart

Global Commercial Partner Manager


Dr. Guido Fritzsch

Senior Sales Manager Europe
Tel.: +49 341 12454 38
Fax: +49 341 12454 60

Sandra Seifert

Global Customer Care Manager
Tel.: +49 341 12454 26
Fax: +49 341 12454 60

Oliver Sasse

Senior Marketing Manager
Tel.: +49 341 12454 27
Fax: +49 341 12454 60


Dr. med. vet. Kate De Roo

Regional Sales Manager France, Benelux, Italy and Spain

Nikita Tandon

Regional Sales Manager UK & Scandics

Dr. med. vet. Mariangela Manfredini

Commercial Partner Development Latin America

Michael Schilling

Regional Market Development Manager North America

Dr. Diana Kadner

Senior Manager Regulatory Affairs and Compliance
Tel.: +49 341 12454 33
Fax: +49 341 12454 60

Dr. Christine Gaunitz

Senior Scientist R&D
Tel.: +49 341 12454 36
Fax: +49 341 12454 60

Board of Directors

INDICAL’s Board of Directors (through holding company Indical TopCo Ab) is responsible for providing guidance to the CEO and Senior Management, overseeing the company strategy and performance by focusing on serving its customers, growing shareholder value, and corporate governance.

Paul Hökfelt

Chairman of the Board,

Paul Hökfelt is also chairman of The Binding Site and AniCura. He is a senior advisor to the Nordic Capital Funds and the founder of Avance Consulting. Following a career in international finance, Paul has been active in the healthcare sector for over 20 years. From 2007 to 2017, Paul spent nearly 10 years as executive chairman of Unilabs. Prior to that, he was president and CEO of the Capio Group. He was also chairman of the board of Clinique La Colline in Geneva. Paul holds a BA from the Stockholm School of Economics.

Gabriel Fitzgerald

Member of the Board,

Gabriel Fitzgerald is the founder of renowned Swedish investment company Fidelio Capital, which he has headed as CEO since 2010. In addition, he is on the boards of Lyko, AniCura and NN07. He previously spent five years at Nordic Capital following a two-year stint in M&A at Carnegie in Stockholm. Gabriel holds an MSc in Finance from the Stockholm School of Economics as well as a medical degree from Linköping University.

Jacob Wiström

Member of the Board,

Jacob Wiström joined Fidelio Capital in 2013 as an investment manager. He has previous experience of M&A and equity capital markets from the corporate finance department of Svenska Handelsbanken. Jacob is also on the board of Greenfood. Jacob holds an BSc in finance and accounting from the Stockholm School of Economics.

Sven Holmlund

Member of the Board,

Sven Holmlund is the chairman of phenotyping specialist LemnaTec, Germany and medical device company Astrego Diagnostics. Previously, he spent 16 years as CEO of Perten Instruments Group, a global supplier of advanced analytical instruments for quality control in the food and agricultural industries. Sven holds a degree in Mechanical Engineering and an MBA.

Helge Lubenow

Member of the Board,

Helge Lubenow held various senior management positions at Qiagen between 1997 and 2015, including senior vice president and head of molecular diagnostic business. She also handled the integration of firms acquired by Qiagen, including Corbett Life Science, Australia, and Digene Inc., USA. In 2016, she founded AGOS Consulting and additionally joined the Supervisory Board of ProteoMediX AG. Helge has a doctorate in genetics from the University of Cologne and the Max Planck Institute for Plant Breeding Research, Cologne.

Research & Development

For over two decades, our expert team of biologists, biochemists, vets, biotechnologists and technical assistants has redefined reliability within diagnostic testing. We use well established techniques to increase test accuracy, improve workflow efficiency, and ensure supply in times of need – so our customers can produce reliable results today, and have certainty for the future.

We operate to the highest quality standards

INDICAL utilizes well established biochemical, immunological and molecular biology techniques, in addition to:

  • World-class S1 and S2 approved laboratories.
  • Certification to handle pathogens in accordance with the German Infectious Disease Control Act and the Animal Pathogen Ordinance, with S1 approval for genetic engineering work.
  • Operations meeting GLP guidelines.
  • Processes certified for DIN EN ISO 9001:2008.

Technical capacities

Molecular biology lab

  • PCR and real-time PCR
  • Recombinant technologies
  • Standard nucleic acid methods
  • Extraction methods

Protein lab

  • Protein expression and purification
  • Mid-scale bacterial cultivation
  • Biochemical and protein analytical methods

Immunological lab

  • ELISA, western blot and other standard immunological technologies
  • Antibody purification and modification